US 11266720
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
granted A61KA61K38/37A61K47/643
Quick answer
US patent 11266720 (Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof) held by BIOVERATIV THERAPEUTICS INC. expires Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- BIOVERATIV THERAPEUTICS INC.
- Grant date
- Tue Mar 08 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 64
- CPC classes
- A61K, A61K38/37, A61K47/643, A61K47/6811, A61P